Clinical Trial Update: Interest of Anti-telomerase T CD4 Immune Responses for Predicting the Effectiveness of Immunotherapies Targeting PD1 / PDL1 [NA]

View source ↗

Summary

This clinical trial update investigates whether anti-telomerase T CD4 immune responses can predict the effectiveness of PD-1/PD-L1 immunotherapies in cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Snippet

Sponsor: Centre Hospitalier Universitaire de Besancon | Conditions: Cancer | NA | Status: COMPLETED